Sclerosing polycystic adenoma (SPA) is a rare salivary gland neoplasm originally thought to represent a non-neoplastic lesion. Recently we have encountered an index case of apocrine intraductal carcinoma of parotid gland of 62-year-old man with invasive salivary duct carcinoma component arising from SPA, a combination of tumor entities that has never been published so far. Here, we further explore the nature of SPA by evaluating 36 cases that were identified from the authors' consultation files. The patients were 25 females and 11 males aged 11 to 79 years (mean, 47.8 y). All tumors originated from the parotid gland. Their size ranged from 11 to 70 mm (mean, 28 mm). Histologically, all cases revealed characteristic features of SPA, such as lobulated well-circumscribed growth, focal hyalinized sclerosis, presence of large acinar cells with abundant brightly eosinophilic intracytoplasmic granules, and ductal components with variable cytomorphologic characteristics, including foamy, vacuolated, apocrine, mucous, clear/ballooned, squamous, columnar and oncocyte-like cells. In all cases, there were foci of intraluminal solid and cribriform intercalated duct-like epithelial proliferations with variable dysplasia which were positive for S100 protein and SOX10, and fully enveloped by an intact layer of myoepithelial cells. In addition, 14/36 cases (39%) had focal intraductal cribriform and micropapillary apocrine-type dysplastic epithelial structures composed of cells positive for androgen receptors and negative for S100/SOX10. The intraductal proliferations of both types showed focal mild to severe dysplasia in 17 cases (17/36; 47%). Two cases showed overt malignant morphology ranging from high-grade intraductal carcinoma to invasive carcinoma with an apocrine ductal phenotype. Next generation sequencing using ArcherDX panel targeting RNA of 36 pan-cancer-related genes and/or a TruSight Oncology 170/500 Kit targeting a selection of DNA from 523 genes and RNA from 55 genes was performed. Tumor tissue was available for molecular analysis in 11 cases, and 9 (9/11; 82%) of them harbored genetic alterations in the PI3K pathway. Targeted sequencing revealed HRAS mutations c.37G>C, p.(Gly13Arg) (2 cases) and c.182A>G, p.(Gln61Arg) (2 cases), and PIK3CA mutations c.3140A>G, p.(His1047Arg) (3 cases), c.1633G>A, p.(Glu545Lys) (1 case), and c.1624G>A, p.(Glu542Lys) (1 case). Moreover, mutations in AKT1 c.49G>A, p.(Glu17Lys) and c.51dup, p.(Tyr18ValfsTer15); c.49_50delinsAG, p.(Glu17Arg) (as a double hit) were found (2 cases). In addition, germinal and somatic mutation of PTEN c.1003C>T, p.(Arg335Ter); c.445C>T, p.(Gln149Ter), respectively, were detected. Gene fusions were absent in all cases. These prevalent molecular alterations converging on one major cancer-related pathway support the notion that SPA is a true neoplasm with a significant potential to develop intraluminal epithelial proliferation with apocrine and/or intercalated duct-like phenotype. The name SPA more correctly reflects the true neoplastic nature of this enigmatic lesion.

Bioptic Laboratory Ltd

Department of Anatomic Histopathology and Cytogenetics Department of Laboratory Medicine Niguarda Cancer Center Milan Italy

Department of Histopathology Division of Clinical Medicine University of Surrey Royal Surrey County Hospital Guildford Surrey UK

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Prague Prague Charles University and Motol University Hospital Prague Czech Republic

Department of Pathology Charles University Faculty of Medicine in Plzen

Department of Pathology CHU Gui de Chauliac Montpellier France

Department of Pathology National University Health System Singapore Singapore

Department of Pathology Research Institute GROW Maastricht University Medical Center Maastricht The Netherlands

Institute of Biomedicine Pathology University of Turku and Turku University Hospital Turku Finland

Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg Erlangen EMN Erlangen Germany

Medical Laboratory CSD Kyiv Ukraine

Molecular and Genetic Laboratory Bioptic Laboratory Ltd Plzen

The Fingerland Department of Pathology Charles University Faculty of Medicine and University Hospital Hradec Kralove Hradec Králové

Zobrazit více v PubMed

Smith BC, Ellis GL, Slater LJ, et al. Sclerosing polycystic adenosis of major salivary glands: a clinicopathologic analysis of nine cases. Am J Surg Pathol. 1996;20:161–170.

Seethala R, Gnepp DR, Skálová A, et al. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. Sclerosing polycystic adenosis. WHO Classification of Head and Neck Tumours. Lyon, France: IARC Press; 2017:195.

Skalova A, Michal M, Simpson RHW, et al. Sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ: report of three cases with immunohistochemical and ultrastructural examination. Virchows Arch. 2002;440:29–35.

Gnepp DR, Wang LJ, Brandwein-Gensler M, et al. Sclerosing polycystic adenosis of the salivary gland. Am J Surg Pathol. 2006;30:154–164.

Fulciniti F, Losito NS, Ionna F, et al. Sclerosing polycystic adenosis of the parotid gland: report of one case diagnosed by fine-needle cytology with in situ malignant transformation. Diagn Cytopathol. 2010;38:368–373.

Manojlović S, Virag M, Milenovič A, et al. Sclerosing polycystic adenosis of parotid gland: a unique report of two cases occurring in two sisters. Pathol Res Pract. 2014;210:342–345.

Petersson F. Sclerosing polycystic adenosis of salivary glands: a review with some emphasis on intraductal epithelial proliferations. Head Neck Pathol. 2013;7(suppl 1):S97–S106.

Petersson F, Tan PH, Hwang JSG. Sclerosing polycystic adenosis of parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking stromal invasion. Head Neck Pathol. 2011;5:188–192.

Skalova A, Gnepp DR, Simpson RHW, et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor locus (HUMARA) as a marker. Am J Surg Pathol. 2006;30:939–944.

Bishop JA, Gagan J, Baumhoer D, et al. Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol. 2020;14:63–636.

Hernandez-Prera J, Heidarian A, Wenig B. Sclerosing polycystic adenoma: conclusive clinical and molecular evidence of its neoplastic nature. Mod Pathol. 2021;34(suppl 2):773–774.

Skalova A, Bishop J, Ferlito A, et al. Newly described entities in salivary gland pathology. Am J Surg Pathol. 2017;41:e33–e47.

Loening T, Leivo I, Simpson RHW, et al. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. Intraductal carcinoma. WHO Classification of Head and Neck Tumours. Lyon, France: IARC Press; 2017:170–171.

Brandwein-Gensler M, Gnepp DR Barnes L, Eveson JW, Reichart P, Sidransky D. Low-grade cribriform cystadenocarcinoma. Pathology and Genetics of Head and Neck Tumours: World Health Organization Classification of Tumours. Lyon, France: IARC; 2005:430.

Weinreb I, Bishop JA, Chiosea SI, et al. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42:442–452.

Skalova A, Vanecek T, Uro-Coste E, et al. Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumor harboring NCOA4-RET and novel TRIM27-RET fusions: report of 17 cases. Am J Surg Pathol. 2018;42:1445–1455.

Skalova A, Ptáková N, Santana T, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors. Is “intraductal” correct? Am J Surg Pathol. 2019;43:1303–1313.

Lu H, Graham RP, Seethala R, et al. Intraductal carcinoma of salivary glands harboring TRIM27-RET fusion with mixed low grade and apocrine types. Head Neck Pathol. 2020;14:239–245.

Bishop JA, Gagan J, Krane JF, et al. Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor. Head Neck Pathol. 2020;14:869–875.

Nagao T, Licitra L, Loening T, et al. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. Salivary duct carcinoma. WHO Classification of Head and Neck Tumours, 4th ed. Lyon, France: IARC Press; 2017:173–174.

Chiosea SI, Williams L, Griffith CC, et al. Molecular characterization of apocrine salivary duct carcinoma. Am J Surg Pathol. 2015;39:744–752.

Dalin MG, Desrichard A, Katabi N, et al. Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin Cancer Res. 2016;22:4623–4633.

Wang K, Russell JS, McDermott JD, et al. Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations. Clin Cancer Res. 2016;22:6061–6068.

Santana T, Andrle P, Martinek P, et al. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Hum Pathol. 2019;93:37–47.

Skalova A, Vanecek T, Martinek P, et al. Molecular profiling of mammary analogue secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol. 2018;42:234–246.

Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–D1067.

Yang J, Nie J, Ma X, et al. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019;18:1–28.

Shimura T, Yuichiro Tada Y, Hirai H, et al. Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas. Oncotarget. 2018;9:1852–1867.

Griffith CC, Seethala RR, Luvison A, et al. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol. 2013;37:1201–1207.

Canas Marques R, Felix A. Invasive carcinoma arising from sclerosing polycystic adenosis of the salivary gland. Virchows Arch. 2014;464:621–625.

Sclerosing mucoepidermoid carcinoma of salivary glands

Apocrine variant of intraductal carcinoma of the parotid gland with sebaceous-like differentiation: expanding morphological and molecular spectrum of an enigmatic entity

Nasal and sinonasal tumors formed by atypical adenomatous lesions arising in respiratory epithelial adenomatoid hamartoma/seromucinous hamartoma

Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands